Probiotic‐derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation

Background and Aims: Intestinal farnesoid X receptor (FXR) plays a critical role in alcohol‐associated liver disease (ALD). We aimed to investigate whether alcohol‐induced dysbiosis increased intestinal microRNA194 (miR194) that suppressed Fxr transcription and whether Lactobacillus rhamnosus GG–derived exosome‐like nanoparticles (LDNPs) protected against ALD through regulation of intestinal miR194‐FXR signaling in mice. Approach and Results: Binge‐on‐chronic alcohol exposure mouse model was utilized. In addition to the decreased ligand‐mediated FXR activation, alcohol feeding repressed intestinal Fxr transcription and increased miR194 expression. This transcriptional suppression of Fxr by miR194 was confirmed in intestinal epithelial Caco‐2 cells and mouse enteriods. The alcohol feeding–reduced intestinal FXR activation was further demonstrated by the reduced FXR reporter activity in fecal samples and by the decreased fibroblast growth factor 15 (Fgf15) messenger RNA (mRNA) in intestine and protein levels in the serum, which caused an increased hepatic bile acid synthesis and lipogeneses. We further demonstrated that alcohol feeding increased‐miR194 expression was mediated by taurine‐upregulated gene 1 (Tug1) through gut microbiota regulation of taurine metabolism. Importantly, 3‐day oral administration of LDNPs increased bile salt hydrolase (BSH)‐harboring bacteria that decreased conjugated bile acids and increased gut taurine concentration, which upregulated Tug1, leading to a suppression of intestinal miR194 expression and recovery of FXR activation. Activated FXR upregulated FGF15 signaling and subsequently reduced hepatic bile acid synthesis and lipogenesis and attenuated ALD. These protective effects of LDNPs were eliminated in intestinal Fxr ΔIEC and Fgf15 −/− mice. We further showed that miR194 was upregulated, whereas BSH activity and taurine levels were decreased in fecal samples of patients with ALD. Conclusions: Our results demonstrated that gut microbiota–mediated miR194 regulation contributes to ALD pathogenesis and to the protective effects of LDNPs through modulating intestinal FXR signaling.

[1]  N. Chalasani,et al.  Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids , 2022, Hepatology communications.

[2]  Ruonan Wu,et al.  Dexmedetomidine hydrochloride inhibits hepatocyte apoptosis and inflammation by activating the lncRNA TUG1/miR-194/SIRT1 signaling pathway , 2021, Journal of inflammation.

[3]  Huaiwen Wang,et al.  Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice. , 2021, Alcoholism, clinical and experimental research.

[4]  M. Merchant,et al.  Exosome‐Like Nanoparticles From Lactobacillus rhamnosus GG Protect Against Alcohol‐Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice , 2021, Hepatology communications.

[5]  J. Kemper,et al.  Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A , 2020, Nature Communications.

[6]  Tetsuya Hayashi,et al.  12α-hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats. , 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[7]  R. Haque,et al.  Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases , 2020, Frontiers in Molecular Biosciences.

[8]  Li Zhang,et al.  Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor , 2020, BMJ open diabetes research & care.

[9]  Yi-horng Lee,et al.  Enhanced Alcoholic Liver Disease in Mice with Intestine-specific Farnesoid X Receptor Deficiency , 2020, Laboratory Investigation.

[10]  Peter T. McKenney,et al.  Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells , 2020, Nature.

[11]  C. McClain,et al.  Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice , 2020, Hepatology.

[12]  G. Xie,et al.  Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism , 2019, Nature Communications.

[13]  Xinmin Yin,et al.  Profiling of Polar Metabolites in Mouse Feces Using Four Analytical Platforms to Study the Effects Of Cathelicidin-Related Antimicrobial Peptide in Alcoholic Liver Disease. , 2019, Journal of proteome research.

[14]  Yi-horng Lee,et al.  FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[15]  Gan Yu,et al.  lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer , 2019, Molecular therapy. Nucleic acids.

[16]  Xingzhen Lao,et al.  Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome , 2019, Microbiome.

[17]  K. Kodys,et al.  FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice , 2018, Hepatology communications.

[18]  Yi-horng Lee,et al.  FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  D. Ciocan,et al.  Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis , 2018, Alimentary pharmacology & therapeutics.

[20]  R. Bataller,et al.  Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. , 2018, Journal of hepatology.

[21]  H. Sokol,et al.  Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice , 2018, Nature Communications.

[22]  D. Brenner,et al.  Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice , 2018, Hepatology.

[23]  Zeyan Chen,et al.  MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[24]  H. Tilg,et al.  Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease , 2017, Gut.

[25]  H. Weiner,et al.  The Host Shapes the Gut Microbiota via Fecal MicroRNA. , 2016, Cell host & microbe.

[26]  K. Kodys,et al.  Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis , 2015, Journal of Translational Medicine.

[27]  H. Nittono,et al.  Innovative and Emerging Technologies in GI Physiology and Disease Colonic inflammation and secondary bile acids in alcoholic cirrhosis , 2014 .

[28]  Chaoqun Huang,et al.  Discrimination of the Expression of Paralogous microRNA Precursors That Share the Same Major Mature Form , 2014, PloS one.

[29]  J. Petrosino,et al.  Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment , 2013, PloS one.

[30]  C. McClain,et al.  Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[31]  C. McClain,et al.  Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. , 2011, The American journal of pathology.

[32]  C. Klaassen,et al.  Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  F. Gonzalez,et al.  Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice , 2010, Laboratory Investigation.

[34]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[35]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[36]  D. Jacobsen,et al.  Taurine supplementation prevents ethanol‐induced decrease in serum adiponectin and reduces hepatic steatosis in rats , 2009, Hepatology.

[37]  T. Osborne,et al.  FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action* , 2009, Journal of Biological Chemistry.

[38]  Timothy D Veenstra,et al.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. , 2009, Genes & development.

[39]  D. Gouma,et al.  High expression of the bile salt‐homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis , 2009, Hepatology.

[40]  C. McClain,et al.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. , 2008, Alcohol.

[41]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[42]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[43]  R. Carithers,et al.  Cholestasis and alcoholic liver disease. , 1999, Clinics in liver disease.